Skip to main content
SpringerLink
Log in

Haemodynamic evaluation of Ibopamine in severe congestive heart failure

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Ten patients suffering from refractory congestive heart failure were treated orally with Ibopamine 100 mg. The haemodynamic effects were evaluated with a Swan-Ganz catheter and thermodilution technique, 1 and 2 h after treatment. Ibopamine significantly increased the cardiac index and stroke work index, and decreased pulmonary pressure and the pulmonary and peripheral vascular resistances without affecting heart rate or blood pressure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Murphy GW, Schreiner BF, Bleakley PL, Yu PN (1964) Left ventricular performance following digitalization in patients with and without heart failure. Circulation 30: 558

    Google Scholar 

  2. Cohn K, Selzer A, Kersh ES, Karpman LS, Goldschlager N (1975) Variability of hemodynamic responses to acute digitalization in chronic cardiac failure due to cardiomyopathy and coronary artery disease. Am J Cardiol 35: 461

    Google Scholar 

  3. Visioli O, Cucchini F, Dei Cas L (1982) Farmaci inotropi positivi adrenergici. Atti XLIII Congresso Nazionale della Società Italiana di Cardiologia, Roma 16–19 Dicembre 1982, p 95

  4. Rajfer SI, Goldberg LI (1982) Dopamine in the treatment of heart failure. Eur Heart J 3: (Suppl D) 103

    Google Scholar 

  5. Chatterjee K, Bendersky R, Parmley WW (1982) Dobutamine in heart failure. Eur Heart J 3: (Suppl D) 107

    Google Scholar 

  6. Klein NA, Siskind SJ, Frishman WH, Sonnenblick EH, Lejemtel TH (1981) Hemodynamic comparison of intravenous Amrinone and Dobutamine in patients with chronic congestive heart failure. Am J Cardiol 48: 170

    Google Scholar 

  7. Lejemtel TH, Keung E, Ribner HS, Davis R, Wexler J, Blanfox MD, Sonnenblick EH (1980) Sustained beneficial effects of oral Amrinone and cardiac and renal function in patients with severe congestive heart failure. Am J Cardiol 45: 123

    Google Scholar 

  8. Rubin SA, Lee S, O'Connor L, Hubenette A, Tober J, Swan HJC (1979) Thrombocytopenia and fever in a patient taking Amrinone. N Engl J Med 301: 1185

    Google Scholar 

  9. Merlo L, Brusoni B, Mussini E, Ghirardi P (1981) Attività della Ibopamina su alterazioni della emodinamica del distretto renale indotte sperimentalmente nel cane narcotizzato. Boll Soc Ital Cardiol 24: 1569

    Google Scholar 

  10. Merlo L, Brusoni B, Mussini E, Ghirardi P (1982) Activity of di-isobutyric ester of N-metil dopamine (Ibopamine) on regional haemodynamics of anaesthetized dogs. Symposium on Dopamine receptors agonists, Stockholm, April 20–23, 1982

  11. Ghirardi P, Bauer R, Brusoni B (1980) Effets d'un dérivé de la dopamine actif par voie orale sur l'excrétion rénale. Nouv Presse Med 9: 453

    Google Scholar 

  12. Dei Cas L, Manca C, Vasini G, Mansour M, Bernardini B, Visioli O (1980) Non-invasive evaluation of left ventricular function through systolic times intervals following oral administration of SB 7505 in man. Arzneimittelforsch 30: 498

    Google Scholar 

  13. Dei Cas L, Vasini G, Manca C, Bernardini B, Visioli O (1982) Non invasive evaluation of the effects of oral Ibopamine (SB 7505) on cardiac and renal function in patients with congestive heart failure. J Cardiovasc Pharmacol 4: 370

    Google Scholar 

  14. Functional Classification of Heart Disease (1966) In: Friedberg CK (ed) Disease of the heart. WB Saunders, Philadelphia, p 241

    Google Scholar 

  15. Marzo A, Ghirardi P, Riva O, Maggi GC, Scalvini A, Marchetti G (1976) Plasma turnover and excretion of K-strophanthoside-3H in human volunteers after parenteral administration. Naunyn Schmied Arch Pharm 294: 115

    Google Scholar 

  16. Marzo A, Ghirardi P, Cavalca L, Alessio R, Maggi GC, Piscitello F, Triulzi MO (1981) Plasma turnover and excretion of Deslanoside C-3H in man after parenteral administration. Farmaco 36: 501

    Google Scholar 

  17. Goldberg LI, Kohli JD (1981) Specific dopamine receptors in vascular smooth muscle. In: Vanhoutte P, Lensen I (eds) Vasodilation. Raven Press, New York, p 131

    Google Scholar 

  18. Longhini C, Musacci GF, Ansani L, Toselli T, Artioli M, Bianco L, Ghirardi P (1983) Effect of Ibopamine on peripheral haemodynamics. Eur J Clin Pharmacol 24: 585–589

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisione Medicina, Ospedale Generale Provinciale, Monselice, Italy

    G. C. Reffo, M. Turrin, A. Gabellini & C. Forattini

  2. Simes S.p.A. La Cardioterapica, Via Bellerio 41, I-20161, Milano, Italia

    Paolo Ghirardi M.D.

Authors
  1. G. C. Reffo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Turrin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Gabellini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Forattini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Paolo Ghirardi M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reffo, G.C., Turrin, M., Gabellini, A. et al. Haemodynamic evaluation of Ibopamine in severe congestive heart failure. Eur J Clin Pharmacol 26, 19–22 (1984). https://doi.org/10.1007/BF00546702

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00546702

Key words

Search

Navigation